These results indicate that Hh signaling is essential for the self-renewal of CD133+ pancreatic cancer cells as exhibited by the sphere formation and the Hh/GLI inhibitor, GANT61, reduced more efficiently than the Hh/SMO inhibitor, cyclopamine. The gene discussed is PROM1; the disease is pancreatic neoplasm.